{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 357,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "% matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 358,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df = pd.read_csv('SearchResults.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 359,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Recruitment</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Verified</th>\n",
       "      <th>First Submitted</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Submitted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Submitted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT03004313</td>\n",
       "      <td>Structural and Molecular Neuroplasticity in Mi...</td>\n",
       "      <td>null</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Migraine</td>\n",
       "      <td>Procedure: Pet Scan|Procedure: MRI scan|Proced...</td>\n",
       "      <td>Level of mu-opioid receptor binding potential ...</td>\n",
       "      <td>University of Michigan</td>\n",
       "      <td>...</td>\n",
       "      <td>October 2014</td>\n",
       "      <td>November 2017</td>\n",
       "      <td>August 30, 2011</td>\n",
       "      <td>December 28, 2016</td>\n",
       "      <td>null</td>\n",
       "      <td>null</td>\n",
       "      <td>November 21, 2017</td>\n",
       "      <td>November 24, 2017</td>\n",
       "      <td>University of Michigan - Michigan Center for O...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03004313</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT00777218</td>\n",
       "      <td>Cognitive Side Effects of Commonly Prescribed ...</td>\n",
       "      <td>null</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Migraine</td>\n",
       "      <td>Drug: propranolol|Drug: zonisamide|Drug: topir...</td>\n",
       "      <td>Record if memory, repetition or recall was imp...</td>\n",
       "      <td>University of South Alabama</td>\n",
       "      <td>...</td>\n",
       "      <td>July 2011</td>\n",
       "      <td>June 2010</td>\n",
       "      <td>October 21, 2008</td>\n",
       "      <td>October 22, 2008</td>\n",
       "      <td>null</td>\n",
       "      <td>null</td>\n",
       "      <td>June 23, 2010</td>\n",
       "      <td>June 24, 2010</td>\n",
       "      <td>University of South Alabama Department of Neur...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00777218</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT01699009</td>\n",
       "      <td>A Nutritional Intervention for Migraines-2</td>\n",
       "      <td>WCCR-MIG2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Migraines</td>\n",
       "      <td>Other: Plant based diet|Other: an unrestricted...</td>\n",
       "      <td>Migraines Pain Change in Migraines frequency|C...</td>\n",
       "      <td>Physicians Committee for Responsible Medicine</td>\n",
       "      <td>...</td>\n",
       "      <td>May 2014</td>\n",
       "      <td>May 2014</td>\n",
       "      <td>October 1, 2012</td>\n",
       "      <td>October 3, 2012</td>\n",
       "      <td>null</td>\n",
       "      <td>null</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>October 20, 2015</td>\n",
       "      <td>Physicians Committee for Responsible Medicine,...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699009</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows Ã— 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT03004313  Structural and Molecular Neuroplasticity in Mi...   \n",
       "1     2  NCT00777218  Cognitive Side Effects of Commonly Prescribed ...   \n",
       "2     3  NCT01699009         A Nutritional Intervention for Migraines-2   \n",
       "\n",
       "     Acronym     Recruitment         Study Results Conditions  \\\n",
       "0       null       Completed  No Results Available   Migraine   \n",
       "1       null  Unknown status  No Results Available   Migraine   \n",
       "2  WCCR-MIG2       Completed  No Results Available  Migraines   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  Procedure: Pet Scan|Procedure: MRI scan|Proced...   \n",
       "1  Drug: propranolol|Drug: zonisamide|Drug: topir...   \n",
       "2  Other: Plant based diet|Other: an unrestricted...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Level of mu-opioid receptor binding potential ...   \n",
       "1  Record if memory, repetition or recall was imp...   \n",
       "2  Migraines Pain Change in Migraines frequency|C...   \n",
       "\n",
       "                           Sponsor/Collaborators  \\\n",
       "0                         University of Michigan   \n",
       "1                    University of South Alabama   \n",
       "2  Physicians Committee for Responsible Medicine   \n",
       "\n",
       "                      ...                      Completion Date  Last Verified  \\\n",
       "0                     ...                         October 2014  November 2017   \n",
       "1                     ...                            July 2011      June 2010   \n",
       "2                     ...                             May 2014       May 2014   \n",
       "\n",
       "    First Submitted       First Posted Results First Submitted  \\\n",
       "0   August 30, 2011  December 28, 2016                    null   \n",
       "1  October 21, 2008   October 22, 2008                    null   \n",
       "2   October 1, 2012    October 3, 2012                    null   \n",
       "\n",
       "  Results First Posted Last Update Submitted Last Update Posted  \\\n",
       "0                 null     November 21, 2017  November 24, 2017   \n",
       "1                 null         June 23, 2010      June 24, 2010   \n",
       "2                 null      October 19, 2015   October 20, 2015   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  University of Michigan - Michigan Center for O...   \n",
       "1  University of South Alabama Department of Neur...   \n",
       "2  Physicians Committee for Responsible Medicine,...   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT03004313  \n",
       "1  https://ClinicalTrials.gov/show/NCT00777218  \n",
       "2  https://ClinicalTrials.gov/show/NCT01699009  \n",
       "\n",
       "[3 rows x 30 columns]"
      ]
     },
     "execution_count": 359,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 360,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'NCT Number', 'Title', 'Acronym', 'Recruitment',\n",
       "       'Study Results', 'Conditions', 'Interventions', 'Outcome Measures',\n",
       "       'Sponsor/Collaborators', 'Gender', 'Age', 'Phases', 'Enrollment',\n",
       "       'Funded Bys', 'Study Type', 'Study Designs', 'Other IDs', 'Start Date',\n",
       "       'Primary Completion Date', 'Completion Date', 'Last Verified',\n",
       "       'First Submitted', 'First Posted', 'Results First Submitted',\n",
       "       'Results First Posted', 'Last Update Submitted', 'Last Update Posted',\n",
       "       'Locations', 'URL'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 360,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 361,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df.columns = ['Rank', 'NCT Number', 'Title', 'Acronym', 'Recruitment',\n",
    "       'Study Results', 'Conditions', 'Interventions', 'Outcome Measures',\n",
    "       'Sponsor_Collaborators', 'Gender', 'Age', 'Phases', 'Enrollment',\n",
    "       'Funded Bys', 'Study Type', 'Study Designs', 'Other IDs', 'Start Date',\n",
    "       'Primary Completion Date', 'Completion Date', 'Last Verified',\n",
    "       'First Submitted', 'First Posted', 'Results First Submitted',\n",
    "       'Results First Posted', 'Last Update Submitted', 'Last Update Posted',\n",
    "       'Locations', 'URL']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 362,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([nan, 'Phase 4', 'Phase 1', 'Phase 2', 'Phase 3', 'Phase 2|Phase 3',\n",
       "       'Phase 1|Phase 2', 'Early Phase 1'], dtype=object)"
      ]
     },
     "execution_count": 362,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.Phases.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 363,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df.Phases.fillna('NA', inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 364,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['NA', 'Phase 4', 'Phase 1', 'Phase 2', 'Phase 3', 'Phase 2|Phase 3',\n",
       "       'Phase 1|Phase 2', 'Early Phase 1'], dtype=object)"
      ]
     },
     "execution_count": 364,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.Phases.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 365,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NA                 131\n",
       "Phase 3             81\n",
       "Phase 4             61\n",
       "Phase 2             55\n",
       "Phase 1             28\n",
       "Phase 2|Phase 3     14\n",
       "Phase 1|Phase 2      8\n",
       "Early Phase 1        1\n",
       "Name: Phases, dtype: int64"
      ]
     },
     "execution_count": 365,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phases = df.Phases.value_counts()\n",
    "df.Phases.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 527,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(-11.233270814556338,\n",
       " 11.011108136059081,\n",
       " -11.119502129951613,\n",
       " 11.098681620350749)"
      ]
     },
     "execution_count": 527,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXcAAADuCAYAAADC3kfBAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\njTEmB/3/KbyEci2/H+UAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x119a8cc18>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots()\n",
    "ax.pie(phases, labels = phases.index, startangle=0, radius = 10)\n",
    "ax.axis('equal')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 367,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "GlaxoSmithKline                                                                                                                                             14\n",
       "Allergan                                                                                                                                                    12\n",
       "Thomas Jefferson University                                                                                                                                 12\n",
       "Eli Lilly and Company                                                                                                                                       11\n",
       "Amgen                                                                                                                                                       10\n",
       "Montefiore Medical Center                                                                                                                                   10\n",
       "Dr. Reddy's Laboratories Limited                                                                                                                             8\n",
       "Alexza Pharmaceuticals, Inc.                                                                                                                                 5\n",
       "Alder Biopharmaceuticals, Inc.                                                                                                                               5\n",
       "NuPathe Inc.|Teva Pharmaceutical Industries                                                                                                                  5\n",
       "POZEN                                                                                                                                                        4\n",
       "Cady, Roger, M.D.|GlaxoSmithKline                                                                                                                            4\n",
       "New York University School of Medicine                                                                                                                       4\n",
       "Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries                                                                                4\n",
       "Pfizer                                                                                                                                                       4\n",
       "Cefaly Technology                                                                                                                                            4\n",
       "Abbott                                                                                                                                                       3\n",
       "Boston Scientific Corporation                                                                                                                                3\n",
       "Beth Israel Deaconess Medical Center                                                                                                                         3\n",
       "Biohaven Pharmaceutical Holding Company Ltd.                                                                                                                 3\n",
       "CoLucid Pharmaceuticals                                                                                                                                      3\n",
       "Johns Hopkins University                                                                                                                                     3\n",
       "Allodynic Therapeutics, LLC                                                                                                                                  3\n",
       "Scion NeuroStim                                                                                                                                              3\n",
       "Novartis                                                                                                                                                     3\n",
       "Cady, Roger, M.D.|Allergan                                                                                                                                   3\n",
       "Avanir Pharmaceuticals                                                                                                                                       2\n",
       "Eisai Inc.                                                                                                                                                   2\n",
       "Georgetown University|U.S. Army Medical Research and Materiel Command                                                                                        2\n",
       "Behar, Caren, M.D.                                                                                                                                           2\n",
       "                                                                                                                                                            ..\n",
       "Thomas Jefferson University|UCB Pharma                                                                                                                       1\n",
       "Seattle Children's Hospital                                                                                                                                  1\n",
       "Michael Rapoff, Ph.D.|National Institute of Neurological Disorders and Stroke (NINDS)|University of Kansas Medical Center                                    1\n",
       "Zosano Pharma Corporation                                                                                                                                    1\n",
       "Tian Medical Inc.|Clinvest                                                                                                                                   1\n",
       "University of Missouri, Kansas City|Truman Medical Center                                                                                                    1\n",
       "Montefiore Medical Center|National Institute of Neurological Disorders and Stroke (NINDS)                                                                    1\n",
       "Ohio University|National Institute of Neurological Disorders and Stroke (NINDS)|Merck Sharp & Dohme Corp.|GlaxoSmithKline                                    1\n",
       "Los Angeles Biomedical Research Institute                                                                                                                    1\n",
       "Cady, Roger, M.D.|Avanir Pharmaceuticals                                                                                                                     1\n",
       "University of Michigan|National Institute of Neurological Disorders and Stroke (NINDS)                                                                       1\n",
       "Amy Gelfand|University of California, Los Angeles|University of California, San Francisco                                                                    1\n",
       "Daniel Benjamin|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|The EMMES Corporation|OpAns, LLC|Duke University     1\n",
       "Emerald City Headache Organization|Ortho-McNeil Neurologics, Inc.                                                                                            1\n",
       "University of Pittsburgh|Pfizer                                                                                                                              1\n",
       "UCB Pharma                                                                                                                                                   1\n",
       "Mood and Anxiety Research, Inc                                                                                                                               1\n",
       "Scott and White Hospital & Clinic                                                                                                                            1\n",
       "Charlottesville Neuroscience|Takeda Pharmaceuticals North America, Inc.                                                                                      1\n",
       "Columbia University|Migraine Research Foundation                                                                                                             1\n",
       "Montefiore Medical Center|Albert Einstein College of Medicine, Inc.                                                                                          1\n",
       "Duke University                                                                                                                                              1\n",
       "Massachusetts General Hospital|National Institutes of Health (NIH)|National Center for Complementary and Integrative Health (NCCIH)                          1\n",
       "XenoPort, Inc.|GlaxoSmithKline                                                                                                                               1\n",
       "Robert W. Baloh|University of California, Los Angeles                                                                                                        1\n",
       "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)                                                                      1\n",
       "MedtronicNeuro                                                                                                                                               1\n",
       "Neurological Research Center|GlaxoSmithKline                                                                                                                 1\n",
       "Johns Hopkins University|National Center for Complementary and Integrative Health (NCCIH)|University of Maryland                                             1\n",
       "Lilian N. Dindo|University of Iowa                                                                                                                           1\n",
       "Name: Sponsor_Collaborators, Length: 231, dtype: int64"
      ]
     },
     "execution_count": 367,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.Sponsor_Collaborators.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 371,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['ASIS Corporation',\n",
       " 'Abbott',\n",
       " 'Achelios Therapeutics',\n",
       " 'Acorda Therapeutics',\n",
       " \"Akron Children's Hospital\",\n",
       " 'Albert Einstein College of Medicine, Inc.',\n",
       " 'Albert Einstein Healthcare Network',\n",
       " 'Alder Biopharmaceuticals, Inc.',\n",
       " 'Alexza Pharmaceuticals, Inc.',\n",
       " 'Alexza Pharmaceuticals, Inc.|PPD',\n",
       " 'Allergan',\n",
       " 'Allergan|MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan',\n",
       " 'Allodynic Therapeutics, LLC',\n",
       " 'Amgen',\n",
       " 'Amy Gelfand|University of California, Los Angeles|University of California, San Francisco',\n",
       " 'Anne Lindblad|National Institute of Neurological Disorders and Stroke (NINDS)|Ortho-McNeil Janssen Scientific Affairs, LLC|The EMMES Corporation',\n",
       " 'AstraZeneca',\n",
       " 'Avanir Pharmaceuticals',\n",
       " 'Behar, Caren, M.D.',\n",
       " 'Benjamin Natelson|Beth Israel Medical Center',\n",
       " 'Beth Israel Deaconess Medical Center',\n",
       " 'BioElectronics Corporation',\n",
       " 'Biohaven Pharmaceutical Holding Company Ltd.',\n",
       " 'Boston Scientific Corporation',\n",
       " 'Bradley Katz|University of Utah',\n",
       " \"Brigham and Women's Hospital\",\n",
       " 'Bristol-Myers Squibb',\n",
       " 'C.R.Darnall Army Medical Center',\n",
       " 'Cady, Roger, M.D.|Allergan',\n",
       " 'Cady, Roger, M.D.|Avanir Pharmaceuticals',\n",
       " 'Cady, Roger, M.D.|GlaxoSmithKline',\n",
       " 'California Medical Clinic for Headache',\n",
       " 'California Pacific Medical Center Research Institute|Kaiser Permanente|Sutter Health|National Center for Complementary and Integrative Health (NCCIH)',\n",
       " 'Capnia, Inc.',\n",
       " 'Capnia, Inc.|Walter Reed National Military Medical Center|United States Naval Medical Center, San Diego|United States Naval Medical Center, Portsmouth|Madigan Army Medical Center',\n",
       " 'Caps Research Network',\n",
       " 'Cardiox Corporation',\n",
       " 'Carilion Clinic|Virginia Polytechnic Institute and State University',\n",
       " 'Carolyn L Turvey|University of Iowa',\n",
       " 'Carrick Institute for Graduate Studies',\n",
       " 'Cefaly Technology',\n",
       " 'Cephalon|Teva Pharmaceutical Industries',\n",
       " 'Charlottesville Neuroscience|Takeda Pharmaceuticals North America, Inc.',\n",
       " \"Children's Hospital Medical Center, Cincinnati|National Institute of Neurological Disorders and Stroke (NINDS)\",\n",
       " \"Children's Hospital Medical Center, Cincinnati|University of Cincinnati\",\n",
       " \"Children's Hospital of Philadelphia\",\n",
       " \"Children's Hospitals and Clinics of Minnesota\",\n",
       " \"Children's Mercy Hospital Kansas City\",\n",
       " 'Clinvest|Endo Pharmaceuticals|Cady, Roger, M.D.',\n",
       " 'Clinvest|Merck Sharp & Dohme Corp.',\n",
       " 'Clinvest|Ortho-McNeil Neurologics, Inc.',\n",
       " 'CoLucid Pharmaceuticals',\n",
       " 'CoLucid Pharmaceuticals|Algorithme Pharma Inc',\n",
       " 'CoLucid Pharmaceuticals|SNBL Clinical Pharmacology Center, Inc.',\n",
       " 'Columbia University|AstraZeneca',\n",
       " 'Columbia University|Migraine Research Foundation',\n",
       " 'Corona Doctors Medical Clinics, Inc.',\n",
       " 'Daniel Benjamin|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|The EMMES Corporation|OpAns, LLC|Duke University',\n",
       " 'Daniel Riche|Migraine Research Foundation|The Oxford Neurology Clinic|University of Mississippi, Oxford',\n",
       " 'Dent Neurologic Institute',\n",
       " 'Dent Neuroscience Research Center',\n",
       " 'Depomed',\n",
       " 'Diamond Headache Clinic|Merck Sharp & Dohme Corp.',\n",
       " \"Dr. Reddy's Laboratories Limited\",\n",
       " 'Duke University',\n",
       " 'Duke University|Agency for Healthcare Research and Quality (AHRQ)|Innovative Medical|Thomas Jefferson University',\n",
       " 'Duramed Research|Teva Pharmaceutical Industries',\n",
       " 'Dynamic Health Resources',\n",
       " 'Eisai Inc.',\n",
       " 'Elan Pharmaceuticals',\n",
       " 'ElectroCore LLC',\n",
       " 'Eli Lilly and Company',\n",
       " 'Emerald City Headache Organization|Ortho-McNeil Neurologics, Inc.',\n",
       " 'Endo Pharmaceuticals',\n",
       " 'Endo Pharmaceuticals|Vernalis (R&D) Ltd',\n",
       " 'Ethicon, Inc.',\n",
       " 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)',\n",
       " 'Gary E. Ruoff, M.D.|GlaxoSmithKline|Westside Family Medical Center, P.C.',\n",
       " 'Georgetown University',\n",
       " 'Georgetown University|U.S. Army Medical Research and Materiel Command',\n",
       " 'GlaxoSmithKline',\n",
       " 'Hartford HealthCare',\n",
       " \"Harvard University Faculty of Medicine|Brigham and Women's Hospital|Palmer Center for Chiropractic Research\",\n",
       " 'HealthPartners Institute|Allergan',\n",
       " 'IMPAX Laboratories, Inc.|AstraZeneca',\n",
       " 'Icahn School of Medicine at Mount Sinai|Endo Pharmaceuticals',\n",
       " 'Indiana University',\n",
       " 'Janssen-Ortho LLC|Ortho-McNeil Neurologics, Inc.',\n",
       " 'Johns Hopkins University',\n",
       " 'Johns Hopkins University|Luitpold Pharmaceuticals',\n",
       " 'Johns Hopkins University|Migraine Research Foundation',\n",
       " 'Johns Hopkins University|National Center for Complementary and Integrative Health (NCCIH)|University of Maryland',\n",
       " 'Johns Hopkins University|University of Toledo Health Science Campus|The Cleveland Clinic',\n",
       " 'Kennedy Medical Group|Teva Pharmaceuticals USA',\n",
       " 'Kern Medical Center',\n",
       " 'Lilian N. Dindo|University of Iowa',\n",
       " 'Los Angeles Biomedical Research Institute',\n",
       " 'Massachusetts General Hospital',\n",
       " 'Massachusetts General Hospital|National Institutes of Health (NIH)|National Center for Complementary and Integrative Health (NCCIH)',\n",
       " 'Mayo Clinic',\n",
       " 'Mayo Clinic|Merck Sharp & Dohme Corp.',\n",
       " 'Mayo Clinic|National Center for Advancing Translational Science (NCATS)',\n",
       " 'Mayo Clinic|Patient-Centered Outcomes Research Institute',\n",
       " 'Mclean Hospital|Endo Pharmaceuticals',\n",
       " 'Mclean Hospital|GlaxoSmithKline',\n",
       " \"Medical College of Wisconsin|Children's Hospital and Health System Foundation, Wisconsin\",\n",
       " 'MedtronicNeuro',\n",
       " 'Memorial Medical Center|United States Department of Defense',\n",
       " 'Michael Rapoff, Ph.D.|National Institute of Neurological Disorders and Stroke (NINDS)|University of Kansas Medical Center',\n",
       " \"Mike O'Callaghan Military Hospital\",\n",
       " 'Monarch Medical Research|Ortho-McNeil Neurologics, Inc.',\n",
       " 'Montefiore Medical Center',\n",
       " 'Montefiore Medical Center|Albert Einstein College of Medicine, Inc.',\n",
       " 'Montefiore Medical Center|National Institute of Neurological Disorders and Stroke (NINDS)',\n",
       " 'Mood and Anxiety Research, Inc',\n",
       " 'NMT Medical',\n",
       " 'National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)',\n",
       " 'National University of Health Sciences',\n",
       " 'NeurAxon Inc.',\n",
       " 'Neuralieve',\n",
       " 'Neurological Research Center|GlaxoSmithKline',\n",
       " 'New York University School of Medicine',\n",
       " 'NorthShore University HealthSystem Research Institute|National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)',\n",
       " 'Northwell Health|Rush University Medical Center|GlaxoSmithKline',\n",
       " 'Novartis',\n",
       " 'NuPathe Inc.|Teva Pharmaceutical Industries',\n",
       " 'Ohio State University|University of Wisconsin, Madison|Massachusetts General Hospital|University Hospitals Cleveland Medical Center',\n",
       " 'Ohio University|National Institute of Neurological Disorders and Stroke (NINDS)|Merck Sharp & Dohme Corp.|GlaxoSmithKline',\n",
       " 'OhioHealth',\n",
       " 'Optinose US Inc.',\n",
       " 'Oregon Health and Science University',\n",
       " 'POZEN',\n",
       " 'Pfizer',\n",
       " 'Pharmalyte Solutions LLC|Clinvest',\n",
       " 'Physicians Committee for Responsible Medicine',\n",
       " \"Planned Parenthood League of Massachusetts|Brigham and Women's Hospital|American Headache Society|Society of Family Planning\",\n",
       " 'Premiere Research Institute|GlaxoSmithKline',\n",
       " 'ProEthic Pharmaceuticals',\n",
       " 'Rami Burstein|Beth Israel Deaconess Medical Center',\n",
       " 'Robert Hickey|University of Pittsburgh',\n",
       " 'Robert W. Baloh|University of California, Los Angeles',\n",
       " 'Roxane Laboratories',\n",
       " 'Rutgers, The State University of New Jersey',\n",
       " 'SK Life Science',\n",
       " 'Scion NeuroStim',\n",
       " 'Scott and White Hospital & Clinic',\n",
       " 'Scott and White Hospital & Clinic|Endo Pharmaceuticals',\n",
       " 'Scripps Health|Depomed',\n",
       " 'Scripps Translational Science Institute',\n",
       " 'Sean Fox|Carolinas Healthcare System',\n",
       " \"Seattle Children's Hospital\",\n",
       " 'Second Opinion Health|Mayo Clinic|University of Southern California|Allergan',\n",
       " 'Shire',\n",
       " 'Smith, Timothy R., M.D.|Clinvest Research, LLC|Ionis Pharmaceuticals, Inc.',\n",
       " 'Solvay Pharmaceuticals|Nektar Therapeutics',\n",
       " 'St. Jude Medical',\n",
       " 'St. Louis University',\n",
       " 'Stanford University',\n",
       " 'Stephen H. Landy, M.D.|GlaxoSmithKline|Wesley Headache Clinic',\n",
       " 'Swedish Medical Center|Takeda',\n",
       " 'Swedish Medical Center|University of Washington|Coherex Medical|The John L. Locke, Jr. Charitable Trust|National Headache Foundation',\n",
       " 'Swedish Medical Center|University of Washington|National Headache Foundation|Wadsworth Foundation|Accumetrics, Inc.',\n",
       " 'Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries',\n",
       " 'Teva Pharmaceutical Industries',\n",
       " 'Teva Pharmaceutical Industries|NCGS, Inc.',\n",
       " 'Texas Cardiac Arrhythmia Research Foundation',\n",
       " 'The Brooklyn Hospital Center',\n",
       " 'The Cleveland Clinic',\n",
       " 'The Cleveland Clinic|Autonomic Technologies, Inc.',\n",
       " 'The Cleveland Clinic|Merck Sharp & Dohme Corp.',\n",
       " 'The Cleveland Clinic|Pernix Theraputics LLC',\n",
       " 'The Cooper Health System',\n",
       " 'The Miriam Hospital|National Institute of Neurological Disorders and Stroke (NINDS)',\n",
       " 'The San Francisco Clinical Research Center',\n",
       " 'Theranica',\n",
       " 'Thomas Jefferson University',\n",
       " 'Thomas Jefferson University|Eli Lilly and Company',\n",
       " 'Thomas Jefferson University|Johnson & Johnson',\n",
       " 'Thomas Jefferson University|UCB Pharma',\n",
       " 'Thomas Jefferson University|Valeant Pharmaceuticals International, Inc.',\n",
       " 'Tian Medical Inc.|Clinvest',\n",
       " 'Tian Medical Inc.|TAMM Net, Inc.|Clinvest Research, LLC',\n",
       " 'Timothy Smith|Mercy Research',\n",
       " 'TorreyPines Therapeutics',\n",
       " 'UCB Pharma',\n",
       " 'United States Naval Medical Center, Portsmouth',\n",
       " 'University Medical Center of Southern Nevada',\n",
       " 'University of Alabama at Birmingham|GlaxoSmithKline',\n",
       " 'University of California, Irvine|American Society of Regional Anesthesia',\n",
       " 'University of California, Los Angeles',\n",
       " 'University of California, San Diego|University of California, Los Angeles|University of California, San Francisco|University of California, Irvine|University of California, Davis',\n",
       " 'University of California, San Francisco|Allergan',\n",
       " 'University of California, San Francisco|American Academy of Otolaryngology-Head and Neck Surgery Foundation',\n",
       " 'University of California, San Francisco|University of California, Los Angeles',\n",
       " 'University of Colorado, Denver',\n",
       " 'University of Georgia|Henry Ford Health System',\n",
       " 'University of Iowa',\n",
       " 'University of Medicine and Dentistry of New Jersey|Endo Pharmaceuticals|Rutgers, The State University of New Jersey',\n",
       " 'University of Medicine and Dentistry of New Jersey|Rutgers, The State University of New Jersey',\n",
       " 'University of Miami|Scion NeuroStim',\n",
       " 'University of Michigan',\n",
       " 'University of Michigan|National Institute of Neurological Disorders and Stroke (NINDS)',\n",
       " 'University of Minnesota - Clinical and Translational Science Institute',\n",
       " 'University of Minnesota - Clinical and Translational Science Institute|Supernus Pharmaceuticals, Inc.',\n",
       " 'University of Missouri, Kansas City|Truman Medical Center',\n",
       " 'University of North Carolina, Chapel Hill|National Center for Complementary and Integrative Health (NCCIH)',\n",
       " 'University of Pennsylvania',\n",
       " 'University of Pittsburgh|Eisai Inc.',\n",
       " 'University of Pittsburgh|Merck Sharp & Dohme Corp.',\n",
       " 'University of Pittsburgh|Pfizer',\n",
       " 'University of South Alabama',\n",
       " 'University of Texas Southwestern Medical Center',\n",
       " 'University of Texas Southwestern Medical Center|Merck Sharp & Dohme Corp.',\n",
       " 'University of Toledo Health Science Campus',\n",
       " \"University of Utah|Axon Optics, LLC|Mayo Clinic|Brigham and Women's Hospital|Northwell Health\",\n",
       " \"University of Utah|Primary Children's Hospital\",\n",
       " 'VA Office of Research and Development',\n",
       " 'VA Office of Research and Development|Thomas Jefferson University|University of Pittsburgh',\n",
       " 'VR1 Corporation',\n",
       " 'Verifomics LLC',\n",
       " 'Vincent Martin, MD|Targeted Medical Pharma',\n",
       " 'Wake Forest University Health Sciences',\n",
       " 'Western University of Health Sciences',\n",
       " 'Westside Family Medical Center, P.C.|GlaxoSmithKline',\n",
       " 'XenoPort, Inc.|GlaxoSmithKline',\n",
       " 'Yale University',\n",
       " 'Zogenix, Inc.',\n",
       " 'Zogenix, Inc.|Synteract, Inc.',\n",
       " 'Zosano Pharma Corporation',\n",
       " 'Zosano Pharma Inc.|Zosano Pharma Corporation',\n",
       " 'eNeura, Inc.|Daniel & Daniel Consulting LLC']"
      ]
     },
     "execution_count": 371,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(df.Sponsor_Collaborators.unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 372,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "df1 = df.head(10)\n",
    "\n",
    "df_expanded = df.head(10)\n",
    "def expandSponsors(df_expanded):\n",
    "    # If there are multiple sponsors split by '|', add rows such that each sponsor gets individual row\n",
    "    #  and delete original row\n",
    "    \n",
    "    drop_index = []\n",
    "\n",
    "    for i, row in df_expanded.iterrows():\n",
    "        index_count = len(df_expanded.index)\n",
    "        lst=[]\n",
    "        lst = row.Sponsor_Collaborators.split('|')\n",
    "        raw_count = len(lst)\n",
    "        if raw_count > 1:\n",
    "            df_expanded = df_expanded.append(pd.DataFrame([row]*raw_count), ignore_index = True)\n",
    "    #        print(len(df_test1.index))\n",
    "            for lst_index, lst_value in enumerate(lst):\n",
    "    #            print(lst_value, index_count + lst_index)\n",
    "                df_expanded.iloc[index_count + lst_index, 9] = lst_value\n",
    "            drop_index.append(i)\n",
    "    df_dropped = df_expanded.drop(drop_index, axis=0)\n",
    "    df_dropped_index_reset = df_dropped.reset_index(drop=True)\n",
    "    return df_dropped_index_reset\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 373,
   "metadata": {},
   "outputs": [],
   "source": [
    "df1 = expandSponsors(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 374,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(565, 30)"
      ]
     },
     "execution_count": 374,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 380,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "GlaxoSmithKline                     28\n",
       "Allergan                            19\n",
       "Thomas Jefferson University         18\n",
       "Teva Pharmaceutical Industries      13\n",
       "Montefiore Medical Center           12\n",
       "Eli Lilly and Company               12\n",
       "Amgen                               10\n",
       "Cady, Roger, M.D.                    9\n",
       "Merck Sharp & Dohme Corp.            9\n",
       "Dr. Reddy's Laboratories Limited     8\n",
       "Name: Sponsor_Collaborators, dtype: int64"
      ]
     },
     "execution_count": 380,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.Sponsor_Collaborators.value_counts().head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 416,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.text.Text at 0x118ce4a90>"
      ]
     },
     "execution_count": 416,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABYMAAASPCAYAAABcR+BMAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n/wHljgaYCdVPnAAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x118532470>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "Top10Sponsors = df1.Sponsor_Collaborators.value_counts().head(10)\n",
    "Top10Sponsors.plot(kind='barh', figsize=(20,20), fontsize=15, xticks = range(0,30,2), grid=True)\n",
    "plt.title('Top 10 Sponsors', fontsize=20)\n",
    "plt.xlabel('Number of Trials Undertaken', fontsize=20)\n",
    "plt.ylabel('Sponsors/Collaborators', fontsize=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 427,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "df_table = df1[df1.Sponsor_Collaborators.isin(Top10Sponsors.index)]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 478,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "df_table1 = df_table[['NCT Number', 'Title', 'Recruitment', 'Phases', 'Enrollment', 'Sponsor_Collaborators']]\n",
    "df_table2 = df_table1.sort_values(['Sponsor_Collaborators', 'Phases'], axis=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 504,
   "metadata": {},
   "outputs": [],
   "source": [
    "Table1 = df_table2.groupby(['Sponsor_Collaborators']).Phases.value_counts().sort_index(level=[0,1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 508,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Sponsor_Collaborators             Phases         \n",
       "Allergan                          NA                  5\n",
       "                                  Phase 2|Phase 3     1\n",
       "                                  Phase 3             7\n",
       "                                  Phase 4             6\n",
       "Amgen                             Phase 1             4\n",
       "                                  Phase 2             4\n",
       "                                  Phase 3             2\n",
       "Cady, Roger, M.D.                 Phase 2             1\n",
       "                                  Phase 4             8\n",
       "Dr. Reddy's Laboratories Limited  Phase 1             1\n",
       "                                  Phase 2             3\n",
       "                                  Phase 3             4\n",
       "Eli Lilly and Company             Early Phase 1       1\n",
       "                                  NA                  1\n",
       "                                  Phase 1             2\n",
       "                                  Phase 2             4\n",
       "                                  Phase 3             4\n",
       "GlaxoSmithKline                   NA                  5\n",
       "                                  Phase 1             2\n",
       "                                  Phase 2             1\n",
       "                                  Phase 2|Phase 3     1\n",
       "                                  Phase 3            11\n",
       "                                  Phase 4             8\n",
       "Merck Sharp & Dohme Corp.         NA                  5\n",
       "                                  Phase 3             2\n",
       "                                  Phase 4             2\n",
       "Montefiore Medical Center         NA                  1\n",
       "                                  Phase 3             2\n",
       "                                  Phase 4             9\n",
       "Teva Pharmaceutical Industries    Phase 1             2\n",
       "                                  Phase 2             3\n",
       "                                  Phase 3             8\n",
       "Thomas Jefferson University       NA                 13\n",
       "                                  Phase 1|Phase 2     1\n",
       "                                  Phase 4             4\n",
       "Name: Phases, dtype: int64"
      ]
     },
     "execution_count": 508,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Table1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 525,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Sponsor_Collaborators</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>Evaluation of ALD403 (Eptinezumab) in the Prev...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Alder Biopharmaceuticals, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>Efficacy, Safety, and Tolerability of Oral Ubr...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Allergan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>Efficacy, Safety, and Tolerability Study of Or...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Allergan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>An Extension Study to Evaluate the Long-Term S...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Allergan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>Zomig - Treatment of Acute Migraine Headache i...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>AstraZeneca</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>Safety and Efficacy in Adult Subjects With Acu...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Biohaven Pharmaceutical Holding Company Ltd.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>Open Label Safety Study in Acute Treatment of ...</td>\n",
       "      <td>Phase 2|Phase 3</td>\n",
       "      <td>Biohaven Pharmaceutical Holding Company Ltd.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>Safety and Efficacy Study in Adult Subjects Wi...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Biohaven Pharmaceutical Holding Company Ltd.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>Lasmiditan Compared to Placebo in the Acute Tr...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>CoLucid Pharmaceuticals</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>Three Doses of Lasmiditan (50 mg, 100 mg and 2...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>CoLucid Pharmaceuticals</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>An Open-label, Long-term, Safety Study of Lasm...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>CoLucid Pharmaceuticals</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>547</th>\n",
       "      <td>Pharmacokinetics of Understudied Drugs Adminis...</td>\n",
       "      <td>NA</td>\n",
       "      <td>Daniel Benjamin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>Pharmacokinetics of Understudied Drugs Adminis...</td>\n",
       "      <td>NA</td>\n",
       "      <td>Duke University</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>548</th>\n",
       "      <td>Pharmacokinetics of Understudied Drugs Adminis...</td>\n",
       "      <td>NA</td>\n",
       "      <td>Eunice Kennedy Shriver National Institute of C...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>The MOTS (Medication Overuse Treatment Strateg...</td>\n",
       "      <td>NA</td>\n",
       "      <td>Mayo Clinic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>Family Study of Affective and Anxiety Spectrum...</td>\n",
       "      <td>NA</td>\n",
       "      <td>National Institute of Mental Health (NIMH)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>Family Study of Affective and Anxiety Spectrum...</td>\n",
       "      <td>NA</td>\n",
       "      <td>National Institutes of Health Clinical Center ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>Pharmacokinetics of Understudied Drugs Adminis...</td>\n",
       "      <td>NA</td>\n",
       "      <td>OpAns, LLC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>To Evaluate the Safety and Efficacy of Trexima...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>POZEN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>To Evaluate the Safety and Efficacy of Trexima...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>POZEN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>The MOTS (Medication Overuse Treatment Strateg...</td>\n",
       "      <td>NA</td>\n",
       "      <td>Patient-Centered Outcomes Research Institute</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>Efficacy and Safety of Subcutaneous Administra...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Teva Branded Pharmaceutical Products, R&amp;D Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>Comparing Efficacy and Safety of 2 Dose Regime...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Teva Branded Pharmaceutical Products, R&amp;D Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>Efficacy and Safety of Subcutaneous Administra...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Teva Pharmaceutical Industries</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>505</th>\n",
       "      <td>Comparing Efficacy and Safety of 2 Dose Regime...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Teva Pharmaceutical Industries</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>Pharmacokinetics of Understudied Drugs Adminis...</td>\n",
       "      <td>NA</td>\n",
       "      <td>The EMMES Corporation</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 Title           Phases  \\\n",
       "188  Evaluation of ALD403 (Eptinezumab) in the Prev...          Phase 3   \n",
       "204  Efficacy, Safety, and Tolerability of Oral Ubr...          Phase 3   \n",
       "205  Efficacy, Safety, and Tolerability Study of Or...          Phase 3   \n",
       "206  An Extension Study to Evaluate the Long-Term S...          Phase 3   \n",
       "194  Zomig - Treatment of Acute Migraine Headache i...          Phase 4   \n",
       "223  Safety and Efficacy in Adult Subjects With Acu...          Phase 3   \n",
       "153  Open Label Safety Study in Acute Treatment of ...  Phase 2|Phase 3   \n",
       "222  Safety and Efficacy Study in Adult Subjects Wi...          Phase 3   \n",
       "189  Lasmiditan Compared to Placebo in the Acute Tr...          Phase 3   \n",
       "191  Three Doses of Lasmiditan (50 mg, 100 mg and 2...          Phase 3   \n",
       "209  An Open-label, Long-term, Safety Study of Lasm...          Phase 3   \n",
       "547  Pharmacokinetics of Understudied Drugs Adminis...               NA   \n",
       "551  Pharmacokinetics of Understudied Drugs Adminis...               NA   \n",
       "548  Pharmacokinetics of Understudied Drugs Adminis...               NA   \n",
       "523  The MOTS (Medication Overuse Treatment Strateg...               NA   \n",
       "545  Family Study of Affective and Anxiety Spectrum...               NA   \n",
       "546  Family Study of Affective and Anxiety Spectrum...               NA   \n",
       "550  Pharmacokinetics of Understudied Drugs Adminis...               NA   \n",
       "115  To Evaluate the Safety and Efficacy of Trexima...          Phase 3   \n",
       "88   To Evaluate the Safety and Efficacy of Trexima...          Phase 3   \n",
       "524  The MOTS (Medication Overuse Treatment Strateg...               NA   \n",
       "496  Efficacy and Safety of Subcutaneous Administra...          Phase 3   \n",
       "504  Comparing Efficacy and Safety of 2 Dose Regime...          Phase 3   \n",
       "497  Efficacy and Safety of Subcutaneous Administra...          Phase 3   \n",
       "505  Comparing Efficacy and Safety of 2 Dose Regime...          Phase 3   \n",
       "549  Pharmacokinetics of Understudied Drugs Adminis...               NA   \n",
       "\n",
       "                                 Sponsor_Collaborators  \n",
       "188                     Alder Biopharmaceuticals, Inc.  \n",
       "204                                           Allergan  \n",
       "205                                           Allergan  \n",
       "206                                           Allergan  \n",
       "194                                        AstraZeneca  \n",
       "223       Biohaven Pharmaceutical Holding Company Ltd.  \n",
       "153       Biohaven Pharmaceutical Holding Company Ltd.  \n",
       "222       Biohaven Pharmaceutical Holding Company Ltd.  \n",
       "189                            CoLucid Pharmaceuticals  \n",
       "191                            CoLucid Pharmaceuticals  \n",
       "209                            CoLucid Pharmaceuticals  \n",
       "547                                    Daniel Benjamin  \n",
       "551                                    Duke University  \n",
       "548  Eunice Kennedy Shriver National Institute of C...  \n",
       "523                                        Mayo Clinic  \n",
       "545         National Institute of Mental Health (NIMH)  \n",
       "546  National Institutes of Health Clinical Center ...  \n",
       "550                                         OpAns, LLC  \n",
       "115                                              POZEN  \n",
       "88                                               POZEN  \n",
       "524       Patient-Centered Outcomes Research Institute  \n",
       "496     Teva Branded Pharmaceutical Products, R&D Inc.  \n",
       "504     Teva Branded Pharmaceutical Products, R&D Inc.  \n",
       "497                     Teva Pharmaceutical Industries  \n",
       "505                     Teva Pharmaceutical Industries  \n",
       "549                              The EMMES Corporation  "
      ]
     },
     "execution_count": 525,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "CondFormat = df1[pd.to_numeric(df1.Enrollment, errors='coerce') > 1000][['Title', 'Phases', 'Sponsor_Collaborators']]\n",
    "CondFormat.sort_values('Sponsor_Collaborators')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
